Direct relationship between suppression of virus-specific immunity and emergence of cytomegalovirus disease in simian AIDS.
Although opportunistic infections like cytomegalovirus (CMV) are common sequelae of end-stage AIDS, the immune events leading to CMV reactivation in human immunodeficiency virus (HIV)-infected individuals are not well defined. The role of cellular and humoral CMV-specific immune responses in immune control of latent CMV infection was evaluated prospectively in a cohort of 11 simian immunodeficiency virus (SIV)-infected CMV-seropositive rhesus macaques, 6 of whom had histologic evidence of CMV disease at death. Macaques with CMV disease differed from macaques without CMV disease in having significantly higher levels of plasma SIV RNA and CMV DNA and significantly lower titers of anti-CMV binding antibodies (Abs) at the time of death. A significant decline in anti-CMV Abs and CMV-specific CD4(+) and CD8(+) T lymphocytes over time was observed in the macaques with CMV disease, but not in the macaques without CMV disease. Reduction in CMV-specific CD8(+) T lymphocytes and anti-CMV neutralizing Abs was significantly correlated with a decline in CMV-specific CD4(+) T lymphocytes. Although declines in CMV-specific T lymphocytes alone were sufficient for reactivation of low-level CMV viremia, high-level viremia (>1,000 copies of CMV DNA per ml of plasma) was observed when anti-CMV neutralizing and binding Abs had also declined. Thus, the occurrence of CMV reactivation-associated disease in AIDS is associated with suppression of both cellular and humoral CMV-specific immune responses. The underlying mechanism may be a dysfunction of memory B and CD8(+) T lymphocytes associated with SIV-induced impairment of CMV-specific CD4(+) T-cell help.
Kaur
Amitinder
A
Division of Immunology, New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts 01772, USA. amitinder_kaur@hms.harvard.edu
Kassis
Nadine
N
Hale
Corrina L
CL
Simon
Meredith
M
Elliott
Michelle
M
Gomez-Yafal
Alicia
A
Lifson
Jeffrey D
JD
Desrosiers
Ronald C
RC
Wang
Fred
F
Barry
Peter
P
Mach
Michael
M
Johnson
R Paul
RP
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood* / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D003587:Cytomegalovirus / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000276:immunology* / Q000503:physiopathology / Q000821:virology; D004279:DNA, Viral / Q000097:blood; D012367:RNA, Viral / Q000097:blood; D016097:Simian Acquired Immunodeficiency Syndrome / Q000150:complications / Q000276:immunology*; D015302:Simian Immunodeficiency Virus / Q000235:genetics / Q000302:isolation & purification; D019562:Viral Load; D014775:Virus Activation
D000914:Antibodies, Viral; D004279:DNA, Viral; D012367:RNA, Viral